Systemic mycosis
MONDO:0000256A mycosis that involves the lungs, abdominal viscera, bones and or central nervous system.
Also known as: systemic fungal infection
55 clinical trials for this condition and its sub-types, 27 tagged with Systemic mycosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Systemic mycosis
-
Opportunistic systemic mycosis 0 trials · 23 incl. sub-types
3 sub-types
- Disseminated candidiasis 16 trials
- Penicilliosis 5 trials
- Trichosporonosis 0 trials · 2 incl. sub-types Sub-types →
-
Primary systemic mycosis 0 trials · 9 incl. sub-types
6 sub-types
- Histoplasmosis 5 trials · 6 incl. sub-types Sub-types →
- Coccidioidomycosis 4 trials
- Blastomycosis 1 trial
- Adiaspiromycosis 0 trials
- Allescheriosis 0 trials
- Paracoccidioidomycosis 0 trials
-
Disseminated sporotrichosis 0 trials
Most studied deeper sub-types
-
New antifungal drug shows promise against deadly fungal infections
Disease control CompletedThis study tested the safety and effectiveness of the antifungal drug isavuconazole as a first treatment for Chinese patients with serious invasive fungal infections caused by Aspergillus or other molds. All 70 participants received the drug for up to 84 days (or 180 days for cer…
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New PET tracer aims to light up hidden infections
Diagnosis CompletedThis early study tested a new radioactive tracer called 18F-FDS in 16 people with suspected bacterial or fungal infections. The tracer is designed to light up infection sites on PET/CT scans, helping doctors see exactly where an infection is. The goal was to check how the tracer …
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New drug could shield transplant patients from deadly fungal infections
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin helps more people stay …
Phase 3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Blood test clues could make antifungal dosing safer for transplant patients
Knowledge-focused CompletedThis study looks back at medical records of transplant recipients (lung, kidney, liver, or bone marrow) who received the antifungal drug isavuconazole. Researchers want to understand why blood levels of the drug vary so much between patients and whether higher levels are linked t…
Sponsor: Zhibin Xu • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Generic antifungal drug shows promise in early comparison study
Knowledge-focused CompletedThis study compared a new generic version of liposomal amphotericin B (an antifungal drug) to the brand-name version (AmBisome®) in 58 healthy Chinese adults. Each volunteer received a single dose of both drugs at different times to see if the generic works the same way in the bo…
Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Generic antifungal drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a new version of the antifungal drug amphotericin B liposome works the same as the original. 42 healthy adults received a single dose of each version at different times. The goal was to see if the drug levels in the blood were similar enough to consider the …
Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Leukemia Patients' hidden threat: fungal infections under microscope
Knowledge-focused CompletedThis study observed 150 adults with a specific type of leukemia (Ph-negative ALL) to see how many developed serious fungal infections during their first weeks of chemotherapy. Researchers tracked infection rates and deaths linked to these infections. The goal was to better unders…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Study questions unnecessary antifungal use in intensive care
Knowledge-focused CompletedThis study looked at whether it's safe to reduce or stop antifungal drugs early in immunocompromised ICU patients suspected of having a fungal infection. Researchers tracked 275 patients across 14 ICUs to see how often doctors de-escalated treatment and what factors influenced th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
PET scans may guide treatment of hidden fungal infection in cancer patients
Knowledge-focused CompletedThis study looked at whether a special type of PET scan can help doctors diagnose and treat a rare fungal infection of the liver and spleen in people with blood cancer or those who had a stem cell transplant. The infection often appears after severe neutropenia (low white blood c…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:07 UTC